IM Cannabis (IMCC) Cash from Restructuring (2020 - 2026)
IM Cannabis (IMCC) posted quarterly Cash from Restructuring of -$5833.6 for Q1 2026, up 16.29% year-over-year from -$5016.3 in Q1 2025, and up 16.29% quarter-over-quarter from -$6969.2 in Q1 2025.
IM Cannabis (IMCC) Cash from Restructuring (2020 - 2026) Analysis & Trends
IM Cannabis' Cash from Restructuring history runs 7 years deep, the most recent figure standing at -$5833.6 for Q1 2026.
- In Q1 2026, Cash from Restructuring rose 16.29% year-over-year to -$5833.6; the TTM figure through Mar 2026 stood at -$34042.2 (up 13.47% YoY), while the FY2022 annual figure was $6.7 million, up 726.66% from the prior year.
- Cash from Restructuring for Q1 2026 stood at -$5833.6, up from -$6969.2 in the prior quarter.
- The five-year high for Cash from Restructuring was $4.5 million in Q2 2022, with the low at -$235991.4 in Q2 2023.
- The 5-year median for Cash from Restructuring is -$7385.4 (2023), against an average of $567168.2.
- The sharpest annual moves came in 2022 and 2024: Cash from Restructuring jumped 34379.47% in 2022, then slumped 105.32% in 2024.
- IM Cannabis' Cash from Restructuring stood at -$11787.2 in 2022, then jumped by 36.72% to -$7459.3 in 2023, then sank by 86.72% to -$13928.0 in 2024, then surged by 49.96% to -$6969.2 in 2025, then gained by 16.29% to -$5833.6 in 2026.
- Business Quant data shows IMCC's Cash from Restructuring at -$5833.6 in Q1 2026, -$6969.2 in Q1 2025, and -$13928.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,833.65 |
| Mar 31, 2025 | -6,969.16 |
| Sep 30, 2024 | -13,928.01 |
| Jun 30, 2024 | -7,311.41 |
| Mar 31, 2024 | -11,131.70 |
| Sep 30, 2023 | -7,459.30 |
| Jun 30, 2023 | -235,991.43 |
| Mar 31, 2023 | 209,334.07 |
| Dec 31, 2022 | -11,787.25 |
| Sep 30, 2022 | -13,801.43 |
| Jun 30, 2022 | 4.49 Mn |
| Mar 31, 2022 | 2.42 Mn |
| Dec 31, 2021 | -344,307.86 |
| Sep 30, 2021 | -725,295.70 |
| Jun 30, 2021 | 13,016.43 |
| Mar 31, 2021 | -12,641.59 |
| Dec 31, 2020 | -13,039.93 |
| Mar 31, 2020 | -12,680.21 |